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Abstract
Background: Video-Assisted Thoracoscopic Sympathectomy (VATS) is an established minimally
invasive procedure for thoracic sympathetic blockade in patients with hyperhidrosis, facial flushing
and intractable angina. Various techniques using clips, diathermy and excision are used to perform
sympathectomy. We present our technique of excision of the sympathetic chain with histological
proof and the analysis of the early and late outcomes.
Methods: We evaluated 200 procedures in 100 consecutive patients, who underwent Video
Assisted Thoracoscopic Sympathectomy by a single surgeon in our centre between September
1996 to March 2007. All patients had maximum medical therapy prior to surgery and were divided
into 3 groups based on indications, Group 1(hyperhidrosis: 48 patients), Group 2 (facial flushing:
26 patients) and Group 3(intractable angina: 26 patients). The demography and severity of
symptoms for each group were analysed. The endpoints were success rate, 30 day mortality,
complications and patient's satisfaction.
Results: 99 patients had bilateral VATS sympathectomy and 1 had unilateral sympathectomy. The
conversion rate to open was 1(1%). All patients had successful removal of ganglia proven
histologically with no perioperative mortality in our series. The complications included
pneumothorax (5%), acute coronary syndrome (2%), transient Horner's syndrome (1%), transient
paraesthesia (1%), wound infection (4%), compensatory hyperhidrosis (18%), residual flushing (3%)
and wound pain (5%). There were five late deaths in the intractable angina group at a mean follow
up of 36.7 months. Overall success rates of abolishing the symptoms were 96.3%, 87.5% and 95.2%
for Group 1, 2 and 3 respectively.
Conclusion: Excision of the sympathetic chain with histological confirmation during VATS
sympathectomy is a safe and effective method in treating hyperhidrosis, facial flushing and
intractable angina with good long term results and satisfaction.
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Thoracoscopic sympathectomy has established itself as a
procedure for a thoracic surgeon since it was first reported
by Hughues in 1942[1] and popularized by Kux [2]. This
was first introduced in 1996 at our regional thoracic sur-
gical unit for the treatment of 3 conditions namely hyper-
hidrosis, facial flushing and intractable angina. We report
our experience of the first hundred patients who had
resection of T2 – T4 sympathetic ganglia along with the
rami communicantes performed by a single surgeon and
their early and long term outcomes.
Methods
A retrospective review of prospectively collected data was
performed on Video Assisted Thoracoscopic Sympathec-
tomies with histological proof of excision to review early
and late outcomes. 100 patients underwent 200 VATS
sympathectomy by a single surgeon in a tertiary thoracic
centre between September 1996 and March 2007 There
were 47 males(47%) with a mean age of 32 years (range
18–80) All patients had maximum medical therapy prior
to surgery. They were classified into 3 groups based on
indications, Group 1: hyperhidrosis, Group 2: facial flush-
ing and Group 3: intractable angina. The distribution of
the cases has been illustrated in figure 1. The study was
approved by the department and discussed with the ethics
committee which advised ethics approval was not
required as this was an outcome audit. Diagnosis was
made in all patients by history and examination. All
patients who underwent the procedure had subjective
symptoms affecting quality of life. The patients in the
hyperhidrosis group had an unsuccessful trial of medical
therapy. Their symptoms were scaled on the basis of
symptoms and impact on quality of life (Grade 1: mini-
mal impact on their QOL, Grade 2: caused significant
impact on quality of life and Grade 3: severe impact on
quality of life). Surgery was only offered to patients with
grade 2 and grade 3 symptoms. In the angina group,
patients were referred with angina refractory to maximal
anti-anginal therapy and deemed unsuitable anatomically
for coronary revascularisation. Initial assessment included
a detailed history with regards to angina symptoms,
degree of disability and effects on quality of life. Patients
had a pre-study exercise tolerance test to assess exercise
capacity and confirm objective evidence of ischaemia.
MUGA scans or transthoracic echocardiogram was per-
formed to determine the left ventricular function. Each
patient's angiogram was reviewed by an independent car-
diologist and cardiothoracic surgeon and confirmed to be
unsuitable for coronary artery bypass grafting or percuta-
neous cardiological intervention.
Procedure
Bilateral VATS sympathectomy was performed under gen-
eral anaesthesia with single lung ventilation starting with
the left side followed by right. We found this approach
helpful in avoiding arrhythmias in patients with intracta-
ble angina. All the patients had electrocardiogram, pulse
oximetry and blood pressure monitored during the proce-
dure. In addition the patients undergoing it for angina
had invasive arterial monitoring as well (in our initial
practice we routinely placed a pulmonary artery floatation
catheter in all patients undergoing sympathectomy for
angina). A slight degree of cranial elevation and the lateral
thoracotomy position helps the lungs to drop away from
the operating site exposing the sympathetic chain. The
first port was placed in the 5th intercostal space below and
anterior to inferior angle of scapula. A 10 mm zero degree
telescope was passed through this port. Two further ports
were placed for instrumentation at the level of the 3rd and
4th intercostal spaces in the anterior axillary line. The
The Distribution of cases in the various groupsFigure 1
The Distribution of cases in the various groups.
Table 1: Patient Satisfaction Outcomes
Group No change Better Very satisfied % improved
Hyperhidrosis (48) 2 9 37 96%
Facial flushing (26) 4 9 13 85%
Intractable angina (26) 2 6 18 92%Page 2 of 6
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chain. An extensive thoracic sympathectomy was per-
formed using electrocautery and excision of thoracic sym-
pathetic chain from 2nd to 4th ganglia along with
associated rami communicantes. In patients with hyper-
hidrosis and facial flushing the parietal pleura was cleared
for 2 cm lateral to the sympathetic chain in the 2nd inter-
costal space. This was performed to identify the accessory
nerve of Kuntz which was then ablated. The excised gan-
glia are confirmed histologically in each case. A redivac
drain was placed in the apex through the anterior port.
The wound was closed in layers with 2'0' vicryl on a 'J-
shaped' needle for the intercostal muscle layer, 2'0' vicryl
for the subcutaneous tissue and 3'0' monocryl for the
skin. Local anaesthetic was infiltrated to the port sites. The
patient was then repositioned and the procedure was
repeated on the contra lateral side.
All the patients were extubated on table and were nursed
in the thoracic surgical ward except the angina patients
who were nursed in the Coronary Care Unit. Patient con-
trolled morphine analgesia was provided for pain relief.
The redivac drains were removed the day after the opera-
tion if the lungs were satisfactorily expanded. Follow-up
was made by outpatient visit, medical notes review, and a
telephone interview of patients who were discharged from
our care. Patients were asked to rate their operative out-
come of the procedure as 1 for no change, 2 for satisfac-
tory and 3 to denote a significant improvement and its
impact on their quality of life.
Results
In the time frame study 100 patients underwent 200 VATS
sympathectomies. Ninety nine patients had bilateral pro-
cedures (one unilateral re operation after 4 years) and one
patient had unilateral procedure. There were no post-
operative deaths. There was conversion to thoracotomy in
the angina group in one patient who had a previous deco-
rtication. The median post operative length of stay was 2.4
days for the facial flushing and hyperhidrosis groups and
5.1 days for the angina group. Early complications
included acute coronary syndrome, pneumothorax,
seroma, transient Horner's syndrome, transient paraesthe-
sia and wound infection as detailed in Table 2. Compen-
satory hyperhidrosis occurred in 18 patients and was not
severe enough to affect their quality of life.
The patients were subjectively assessed for their symptoms
in the out patients clinic at 4 weeks, 3 months and 6
months and the care was transferred to the referring clini-
cian. Late outcomes were obtained through telephone-
conducted patient interviews. All patients were graded for
their improvement in the symptoms as 1 for no change, 2
for better and 3 for satisfied. In the hyperhidrosis group
46 patients (96%) were satisfied with the procedure. In
the facial flushing group 22(85%) were satisfied with the
procedure (Figure 2).
The angina group were assessed by their pre and post pro-
cedure Canadian Cardiovascular score for angina, subjec-
tive angina score out of 10 and frequency of anginal
episodes. Of the twenty five patients who underwent the
procedure for relief of refractory angina only one patient
(4%) did not feel any difference all the rest had an imme-
diate relief in their symptoms. One patient had atrial
fibrillation and two had a post operative myocardial inf-
arction in the early post operative phase.
Follow up
Full follow-up was available for a mean 67.8 months. In
the angina group there were 5 deaths at a mean of 28.75
+/- 13.7 months after procedure. Of these, 2 deaths were
cardiac related deaths, one patient died of lung cancer,
one patient due to perforated bowel and one died of ter-
minal colonic cancer. The patients who died had sympto-
matic relief and were satisfied with the operation. On late
follow-up 1 patient continued to have anginal symptoms
and there was recurrence of angina in two patients at a fol-
low up of 3 and 36 months. Of these patients with recur-
rence one patient the angina symptoms were present only
on the right side and one patient had a dorsal spinal cord
stimulator fitted which offered him relief.
In the hyperhidrosis group one patient was noted to have
unilateral persistence of sweating and he underwent a re
do right sympathectomy after four years which abolished
his symptoms. In the original operation the T 2 sym-
pathectomy was not performed on the right due to the
presence of large veins this was remedied in the second
operation. 4 (15%) patients of facial flushing group had
residual facial flushing. 18 patients (18%) had compensa-
tory hyperhidrosis but none found this complication to
adversely affect their quality of life. Five patients had post
thoracoscopic pain of which one had chronic pain need-
ing referral to the pain clinic. The patient satisfaction
results are tabulated in table 1/figure 2.
Table 2: Early complications
Complication Number of patients %
Acute coronary syndrome 2 2%
Pneumothorax 5 5%
Transient Horner's Syndrome 1 1%
Transient Parasthesia 1 1%
Compensatory hyperhidrosis 18 18%
Wound infection 4 4%
Seroma 1 1%Page 3 of 6
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VATS sympathectomy is an established therapeutic option
for hyperhidrosis [3], facial flushing [4], Raynaud's dis-
ease [5] and ischaemic heart disease [6].
Primary or essential Hyperhidrosis is a functionally, pro-
fessionally, and socially disabling condition. It is a patho-
logical condition characterized by excessive secretion of
the eccrine glands resulting in overpespiration dispropor-
tionate to the requirements of thermoregulation and dis-
sipation of body heat [7]. The current medical treatment
modalities for hyperhidrosis include topical application
of aluminium salts, tap water iontophoresis, botulinum
toxin injections, behavioural and psychotherapy with lim-
ited success [8]. The pathophysiology of facial flushing is
uncertain, but it is thought to involve vasomotor and
sudomotor imbalances [4].
In patients unsuitable for surgical intervention but with
intractable angina therapeutic options included long-term
intermittent urokinase, spinal cord stimulation and Trans
Myocardial Revascularisation. Wettervik showed that
VATS sympathectomy had encouraging early results in
this group of patient [9]. Benefit is thought to be related
to pain anaesthesia of the upper thoracic sympathetic
afferent and efferent fibres[10] and vasodilatation follow-
ing coronary blockade of alpha adreno receptor mediated
sympathetic vasoconstriction [11].
Several groups have adopted a single or two port tech-
nique for VATS sympathectomy [7,12,13]. In our series we
performed the procedure with the 3-port technique, since
it allows accurate, safe and reproducible dissection of the
thoracic sympathetic chain. We use conventional Thora-
coscopic instruments (i.e. no articulating instruments)
and training residents is much easier with the three port
technique.
Excision of the appropriate sympathetic ganglia is essen-
tial for effective post operative outcomes. Excision of the
lower third of the stellate ganglia increases the risk of
Horner's syndrome [14]. Removal of ganglia between T2
– T4 is optimal for sympathetic denervation of the upper
limb [15]. In the treatment of intractable angina we have
shown that T2 – T4 sympathectomy was sufficient to alle-
viate symptoms without risking undue hypotension and
Horner's syndrome associated with more extensive exci-
sion. Excision of the second to fourth sympathetic ganglia
as opposed to clipping [16] or electro coagulation [17]
may reduce the incidence of recurrence. In patients with
hyperhidrosis and facial flushing, the nerve of Kuntz was
excised to reduce recurrence[18,19].
The patient satisfaction outcomesFigure 2
The patient satisfaction outcomes.Page 4 of 6
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tomy involves sensitization produced by section of post-
ganglionic fibres. In our study the recurrence of
hyperhidrosis was 2% which is comparable to that
reported in the literature 6.5% reported in literature [20].
The most common complication of thoracic sympathec-
tomy is transient compensatory sweating probably due to
thermoregulatory imbalance. This occurred in 18% of the
patients in our study which is consistent with the reported
incidence of 20% to 86% [21-23]. We feel the major
adverse complications in our series are less due to the
three port technique and better visualisation. We did not
have any vascular injuries, reexplorations for bleeding,
permanent Horner's syndrome or chylothorax which are
reported in the literature [22].
We have demonstrated that patients with intractable
angina treated with VATS sympathectomy, had a decrease
in angina score and frequency of angina as well as an
improvement in exercise tolerance [6]. One of the con-
cerns with this procedure was that the denervation of the
heart might result in silent ischaemia and mortality,
which has not been the case. The other concern was if den-
ervation leads to symptom relief why this was not a com-
plete abolition of symptoms. We feel the benefits are
individualised because the sympathetic innervation is col-
lateralised from the aortic plexus which derives its fibres
from the cervical plexus. In this current study, we have
studied the long term outcomes of the same and noted
persistent benefit in symptom alleviation. VATS sym-
pathectomy is a durable palliation for symptoms of
angina in a group with few other reliable therapeutic
options.
It is our policy to send the excised sympathetic chain for
histological confirmation as a quality control measure.
We feel this is a good practice in the current medico legal
climate so that the surgeon can demonstrate the chain was
excised.
Conclusion
Video assisted thoracoscopic sympathectomy with histo-
logical proof of excision is a safe and effective procedure
attended by low complications. It is an effective treatment
for hyperhidrosis and facial flushing with good long term
benefits and patient satisfaction. It offers lasting relief
from angina and improves quality of life in patients with
intractable angina without options of conventional revas-
cularisation. Histological confirmation of the excised
sympathetic chain is valuable for medico-legal documen-
tation.
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